z-logo
open-access-imgOpen Access
miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma
Author(s) -
Jiashi Wang,
Guangbin Wang,
Bin Li,
Chuang Qiu,
Ming He
Publication year - 2018
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s171304
Subject(s) - osteosarcoma , western blot , cell growth , microrna , cancer research , apoptosis , immunohistochemistry , transfection , biology , microbiology and biotechnology , cell culture , gene , immunology , biochemistry , genetics
Many studies have used miRNA to modulate osteosarcoma development by regulating protein expression, and these studies showed that the expression of EGFR is increased in osteosarcoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom